That cells within different maturation stages have the capacity to engraft B-ALL and contain stem cell activity was confirmed by showing that both CD19+/CD20- and CD19+/CD20+ cells are capable of B-ALL engraftment. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.